drugset / Trial / NCT01189214

Psychopharmacotherapy in Multiple Substances Abuse

NCT01189214

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Add-on of memantine or placebo treatment will proceed in a double-blinded fashion for 12 weeks after adjusted methadone dose. During the study, the investigators will evaluate treatment response and adverse effect from multiple dimensions to elucidate the therapeutic effect of add-on memantine on addictive behaviors. It will also explore the possible advantage of this treatment on social re-adaptation and psychopathogenesis of opioid dependence.

Timeline

Start
2009-03
Primary completion
2011-02
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Memantine Unknown

Indications